Skip to main content

UBS Group AG

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in IKT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$415,447
+$32,154 QoQ
Shares Held
204,654
-10.3% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 106 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. IKT ranks #307 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IKT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $415,447 204,654
2026-03-31 $383,293 228,151
2025-12-31 $193,817 94,545
2025-09-30 $220,773 136,280
2025-06-30 $75,414 38,674
2025-03-31 $99,132 45,266
2024-12-31 $89,458 27,526
2024-09-30 $6,334 4,873
2024-03-31 $6,942 3,214
2023-09-30 $207 149
2022-12-31 $65 130
2022-09-30 $6,824 7,499
2022-03-31 $7,565 5,112
2021-12-31 $2,585 1,759
2021-09-30 $16,241 8,548